Researchers say they're getting closer to creating long-acting drugs for HIV, negating the need for daily or even twice-daily pills.
Experts say knocking down barriers is essential for these treatments to make it accessible for everyone, especially helpful for harder-to-reach patients.
For more on this, KCBS Radio news anchor Pat Thurston spoke with Dr. Monica Gandhi, Professor at UC San Francisco and director of the UCSF Gladstone Center for AIDS research, and Medical Director of the San Francisco General Hospital HIV clinic.